BRCA2 and breast carcinoma: Although other breast cancer risk alleles of moderate penetrance have recently been identified, only BRCA1 and BRCA2 are routinely evaluated in genetic counseling settings in order to identify carriers for purposes of assessing cancer risk and offering management strategies for cancer detection and prevention [2].